文献速递血栓与止血

从肝素诱导性血小板减少症患者克隆的抗体为HIT发病机制提供新线索

Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis.
PubMed 文献 · Blood · 2023-01-01

研究从6例肝素诱导性血小板减少症(HIT)患者中克隆出7个血小板活化(PA)抗体和47个非活化(NA)PF4/肝素结合抗体,发现PA克隆具有两种重链互补决定区3基序之一(RKH或Y5)且互补决定区3异常长(≥20个残基),突变这些基序可降低或消除PA活性,HIT患者外周血IgG+ B细胞中携带RKH或Y5的频率显著高于接受肝素的无HIT患者。

要点

  • PA克隆与NA克隆的区别在于具有RKH或Y5基序且CDR3异常长(≥20个残基)。
  • 修饰PA克隆的任一基序可降低或消除其血小板活化活性。
  • HIT患者外周血IgG+ B细胞中RKH或Y5频率显著高于无HIT的肝素治疗患者。

核心结论

  • 具有RKH或Y5基序的抗体与HIT发病机制相关,并提示诊断和治疗该病的新方法。

研究设计与样本

  • 从6例HIT患者中克隆7个PA和47个PF4/肝素结合抗体,并表征其结构和功能特性。

主要发现

  • PA克隆与NA克隆的显著差异在于具有RKH或Y5基序之一且互补决定区3异常长(≥20个残基)。
  • 诱变研究显示修饰PA克隆的任一基序可降低或消除其PA活性。
  • NA克隆HCDR3中适当的氨基酸替换可使其变为PA。
  • repertoire测序显示HIT患者外周血IgG+ B细胞中RKH或Y5频率显著高于接受肝素的无HIT患者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heparin-induced thrombocytopenia (HIT) is a serious adverse drug reaction characterized by antibodies that recognize platelet factor 4/heparin complexes (PF4/H) and activate platelets to create a prothrombotic state. Although a high percentage of heparin-treated patients produce antibodies to PF4/H, only a subset also makes antibodies that are platelet activating (PA). A close correlation between PA antibodies and the likelihood of experiencing HIT has been demonstrated in clinical studies, but how PA (presumptively pathogenic) and nonactivating (NA) (presumptively benign) antibodies differ from each other at the molecular level is unknown. To address this issue, we cloned 7 PA and 47 NA PF4/H-binding antibodies from 6 patients with HIT and characterized their structural and functional properties. Findings showed that PA clones differed significantly from NA clones in possessing 1 of 2 heavy chain complementarity-determining region 3 (HCDR3) motifs, RX1-2R/KX1-2R/H (RKH) and YYYYY (Y5), in an unusually long complementarity-determining region 3 (≥20 residues). Mutagenic studies showed that modification of either motif in PA clones reduced or abolished their PA activity and that appropriate amino acid substitutions in HCDR3 of NA clones can cause them to become PA. Repertoire sequencing showed that the frequency of peripheral blood IgG+ B cells possessing RKH or Y5 was significantly higher in patients with HIT than in patients without HIT given heparin, indicating expansion of B cells possessing RKH or Y5 in HIT. These findings imply that antibodies possessing RKH or Y5 are relevant to HIT pathogenesis and suggest new approaches to diagnosis and treatment of this condition.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Zhu W, Zheng Y, Yu M, et al. Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis. Blood. 2023. PMID: 36493339. doi:10.1182/blood.2022017612

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。